{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:50Z","timestamp":1792786130526,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Saudi Arabian Cultural Bureau","id":[{"id":"https:\/\/ror.org\/044weyr28","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>There is substantial evidence that the autonomic nervous system plays a crucial role in pain modulation and chronicity, but the actual prevalence of dysautonomia in musculoskeletal conditions remains unknown. This study investigated the prevalence of dysautonomia in patients with chronic musculoskeletal pain (CMP) compared with healthy controls, quantified the dysautonomia burden in inflammatory and non-inflammatory musculoskeletal conditions, and evaluated the associations between pain severity, psychological factors and dysautonomia severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study recruited patients with CMP between October 2024 and July 2025 along with healthy participants with similar age-sex distribution. Inclusion criteria were a clinician-confirmed musculoskeletal condition and pain duration &amp;gt;12\u2009weeks. Assessments included the Composite Autonomic Symptom Score-31, the Brief Pain Inventory and the Hospital Anxiety and Depression Scale. A COMPASS-31 score of 17 or higher was considered indicative of dysautonomia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 896 patients screened, 342 participated, along with 57 healthy controls. Dysautonomia was significantly more prevalent in CMP patients (74%) compared with controls (11%) (adjusted RR\u2009=\u20097.4, 95% CI 1.8\u201313.1, P\u2009=\u20090.010). Dysautonomia rates were similarly high in inflammatory (76%) and non-inflammatory (72%) conditions. Risk of dysautonomia increased with pain severity (RR 1.27 per point on BPI, 95% CI 1.08\u20131.45, P\u2009&amp;lt;\u20090.001), depression (RR 1.12 per HADS depression score, 95% CI 1.06\u20131.19, P\u2009&amp;lt;\u20090.001) and anxiety (RR 1.15 per HADS anxiety score, 95% CI 1.08\u20131.22, P\u2009&amp;lt;\u20090.001), adjusting for age and gender.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dysautonomia is highly prevalent among patients with CMP irrespective of inflammatory status and is associated with pain severity, depression and anxiety. CMP patients should be assessed for dysautonomia as a potential contributor to symptom burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag511","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:35:22Z","timestamp":1789619722000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of dysautonomia in chronic musculoskeletal pain: a cross-sectional study"],"prefix":"10.1093","volume":"65","author":[{"given":"Norah A","family":"Almutairi","sequence":"first","affiliation":[{"name":"Academic Department of Rehabilitation Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"Physical Therapy and Rehabilitation Department, College of Applied Medical Sciences, Majmaah University , Majmaah,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-3096","authenticated-orcid":false,"given":"Darren C","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"Leeds Institute for Data Analytics, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Sivan","sequence":"additional","affiliation":[{"name":"Academic Department of Rehabilitation Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds,","place":["UK"]},{"name":"National Demonstration Centre of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026092611113084700_keag511-B1","author":"World Health Organization","year":"2022"},{"key":"2026092611113084700_keag511-B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/j.pain.0000000000001389","article-title":"The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain","volume":"160","author":"Perrot","year":"2019","journal-title":"Pain"},{"key":"2026092611113084700_keag511-B3","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(20)32340-0","article-title":"Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Cieza","year":"2021","journal-title":"Lancet"},{"key":"2026092611113084700_keag511-B4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.berh.2010.01.012","article-title":"Epidemiology of chronic musculoskeletal pain","volume":"25","author":"Cimmino","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026092611113084700_keag511-B5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"2026092611113084700_keag511-B6","author":"Hallman","year":"2012"},{"key":"2026092611113084700_keag511-B7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12017-007-8018-6","article-title":"The sympathetic nervous system and pain","volume":"10","author":"Schlereth","year":"2008","journal-title":"Neuromolecular Med"},{"key":"2026092611113084700_keag511-B8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-022-01071-9","article-title":"Autonomic nervous system dysregulation and osteoarthritis pain: mechanisms, measurement, and future outlook","volume":"24","author":"Yeater","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"2026092611113084700_keag511-B9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12026-025-09661-2","article-title":"Dysautonomia: a common comorbidity of systemic disease","volume":"73","author":"Blitshteyn","year":"2025","journal-title":"Immunol Res"},{"key":"2026092611113084700_keag511-B10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"2026092611113084700_keag511-B11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0b013e3181a1083d","article-title":"Autonomic dysfunction in fibromyalgia assessed by the Composite Autonomic Symptoms Scale (COMPASS)","volume":"15","author":"Solano","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"2026092611113084700_keag511-B12","first-page":"1054","article-title":"Composite Autonomic Symptom Score 31 (COMPASS-31) for the assessment of symptoms of autonomic dysfunction in fibromyalgia","volume":"43","author":"Salaffi","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"2026092611113084700_keag511-B13","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"2026092611113084700_keag511-B14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2026092611113084700_keag511-B15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ANA.0000000000000824","article-title":"The utility of COMPASS-31 questionnaire to predict autonomic dysfunction in patients with cervical\/upper thoracic compressive myelopathy","volume":"35","author":"Takri","year":"2023","journal-title":"J Neurosurg Anesthesiol"},{"key":"2026092611113084700_keag511-B16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/ene.12717","article-title":"Validation of The Composite Autonomic Symptom Scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy","volume":"22","author":"Treister","year":"2015","journal-title":"Eur J Neurol"},{"key":"2026092611113084700_keag511-B17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1574887116666210612033002","article-title":"Clinical assessment of autonomic function in fibromyalgia by the refined and abbreviated Composite Autonomic Symptom Score (COMPASS 31): a case-controlled study","volume":"17","author":"Puri","year":"2022","journal-title":"Rev Recent Clin Trials"},{"key":"2026092611113084700_keag511-B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale: an updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"2026092611113084700_keag511-B19","doi-asserted-by":"crossref","first-page":"100071","DOI":"10.1016\/j.ijchy.2020.100071","article-title":"Initial orthostatic hypotension and orthostatic intolerance symptom prevalence in older adults: a systematic review","volume":"8","author":"Christopoulos","year":"2021","journal-title":"Int J Cardiol Hypertens"},{"key":"2026092611113084700_keag511-B20","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.3390\/ijerph20105804","article-title":"Detecting orthostatic intolerance in long COVID in a clinic setting","volume":"20","author":"Isaac","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026092611113084700_keag511-B21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton Neurosci"},{"key":"2026092611113084700_keag511-B22","first-page":"23743735251314652","article-title":"The diagnostic journey of dysautonomia patients: insights from a patient-reported outcome study","volume":"12","author":"O\u2019Dell","year":"2025","journal-title":"J Patient Exp"},{"key":"2026092611113084700_keag511-B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/92.2.97","article-title":"Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"92","author":"Louthrenoo","year":"1999","journal-title":"QJM"},{"key":"2026092611113084700_keag511-B24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00296-005-0093-0","article-title":"Autonomic dysfunction in systemic lupus erythematosus","volume":"26","author":"Handa","year":"2006","journal-title":"Rheumatol Int"},{"key":"2026092611113084700_keag511-B25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0019-5154.182410","article-title":"Methodology series module 3: cross-sectional studies","volume":"61","author":"Setia","year":"2016","journal-title":"Indian J Dermatol"},{"key":"2026092611113084700_keag511-B26","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/s41598-024-52368-x","article-title":"Mismatch between subjective and objective dysautonomia","volume":"14","author":"Novak","year":"2024","journal-title":"Sci Rep"},{"key":"2026092611113084700_keag511-B27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/dme.13310","article-title":"Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes","volume":"34","author":"Greco","year":"2017","journal-title":"Diabet Med"},{"key":"2026092611113084700_keag511-B28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00296-022-05110-7","article-title":"Assessment of autonomic dysfunction with the COMPASS-31 and its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis","volume":"42","author":"Gezer","year":"2022","journal-title":"Rheumatol Int"},{"key":"2026092611113084700_keag511-B29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pmrj.2015.08.008","article-title":"Patients with fibromyalgia have significant autonomic symptoms but modest autonomic dysfunction","volume":"8","author":"Vincent","year":"2016","journal-title":"PM R"},{"key":"2026092611113084700_keag511-B30","first-page":"10","article-title":"The adapted autonomic profile (aAP) home-based test for the evaluation of neuro-cardiovascular autonomic dysfunction","volume":"21","author":"Sivan","year":"2022","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"2026092611113084700_keag511-B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-444-52901-5.00020-4","article-title":"Autonomic dysfunction: recognition, diagnosis, investigation, management, and autonomic neurorehabilitation","volume":"110","author":"Mathias","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"2026092611113084700_keag511-B32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10072-021-05810-1","article-title":"Structural and functional connections between the autonomic nervous system, hypothalamic\u2013pituitary\u2013adrenal axis, and the immune system: a context and time dependent stress response network","volume":"43","author":"Mueller","year":"2022","journal-title":"Neurol Sci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag511\/71151815\/keag511.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag511\/71151815\/keag511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag511\/71151815\/keag511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:11:43Z","timestamp":1790435503000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag511\/8806172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag511","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"keag511"}}